FH and renal cell carcinoma: In a focused study on a specific RCC subtype, Dong et al. [242] investigated genomic characteristics and single-cell profiles in fumarate hydratase-deficient RCC following immunotherapy, revealing unique response patterns and potential therapeutic targets for this rare but aggressive variant.